StonvexLoading…
StonvexStonvexStonvexCore line items from RVMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-1.18B | $-689.52M | $-473.21M | $-297.50M |
Net Income | $-1.13B | $-600.09M | $-405.52M | $-133.23M |
EPS (Diluted) | $-5.95 | $-3.58 | $-2.45 | $-1.51 |
Total Assets | $2.35B | $2.56B | $1.76B | $1.81B |
Total Liabilities | $723.21M | $293.10M | $196.69M | $189.59M |
Cash & Equivalents | $383.75M | $543.06M | $201.26M | $275.71M |
Free Cash Flow OCF − CapEx | $-913.73M | $-567.74M | $-428.23M | $-294.29M |
Shares Outstanding | 197.00M | 185.90M | 167.75M | 165.65M |